Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 2
1981 1
1985 2
1986 2
1988 1
1995 1
2002 4
2003 1
2004 4
2005 4
2006 4
2007 1
2008 4
2009 3
2010 1
2011 3
2012 1
2013 2
2014 1
2015 3
2016 4
2017 1
2019 5
2020 1
2023 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Sipuleucel-T immunotherapy for castration-resistant prostate cancer.
Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, Xu Y, Frohlich MW, Schellhammer PF; IMPACT Study Investigators. Kantoff PW, et al. N Engl J Med. 2010 Jul 29;363(5):411-22. doi: 10.1056/NEJMoa1001294. N Engl J Med. 2010. PMID: 20818862 Free article. Clinical Trial.
Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer.
Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Kappeler C, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. N Engl J Med. 2019 Mar 28;380(13):1235-1246. doi: 10.1056/NEJMoa1815671. Epub 2019 Feb 14. N Engl J Med. 2019. PMID: 30763142 Clinical Trial.
Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide.
Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Le Berre MA, Petrenciuc O, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. N Engl J Med. 2020 Sep 10;383(11):1040-1049. doi: 10.1056/NEJMoa2001342. N Engl J Med. 2020. PMID: 32905676 Clinical Trial.
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study.
Tabernero J, Yoshino T, Cohn AL, Obermannova R, Bodoky G, Garcia-Carbonero R, Ciuleanu TE, Portnoy DC, Van Cutsem E, Grothey A, Prausová J, Garcia-Alfonso P, Yamazaki K, Clingan PR, Lonardi S, Kim TW, Simms L, Chang SC, Nasroulah F; RAISE Study Investigators. Tabernero J, et al. Lancet Oncol. 2015 May;16(5):499-508. doi: 10.1016/S1470-2045(15)70127-0. Epub 2015 Apr 12. Lancet Oncol. 2015. PMID: 25877855 Clinical Trial.
Playing mathematics.
Wertheim M. Wertheim M. Ann N Y Acad Sci. 2019 Dec;1458(1):70-74. doi: 10.1111/nyas.14269. Epub 2019 Oct 28. Ann N Y Acad Sci. 2019. PMID: 31658380
Corneal transplant rejection following influenza vaccination.
Wertheim MS, Keel M, Cook SD, Tole DM. Wertheim MS, et al. Br J Ophthalmol. 2006 Jul;90(7):925. doi: 10.1136/bjo.2006.093187. Br J Ophthalmol. 2006. PMID: 16782961 Free PMC article. Review. No abstract available.
The mystery of our mathematical universe.
Paulson S, Gates SJ Jr, Wertheim M. Paulson S, et al. Among authors: wertheim m. Ann N Y Acad Sci. 2019 Dec;1458(1):9-25. doi: 10.1111/nyas.14026. Epub 2019 Mar 22. Ann N Y Acad Sci. 2019. PMID: 30900261
Diamonds are forever!
Ross AH, Wertheim MS, Dick AD, Majid MA. Ross AH, et al. Among authors: wertheim ms. Eye (Lond). 2009 May;23(5):1228. doi: 10.1038/eye.2008.186. Epub 2008 Jun 20. Eye (Lond). 2009. PMID: 18566612 No abstract available.
53 results